The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
A quick guide to the quirks, qualifications, and questionable decisions the invited pharma leaders will bring to next week's Senate hearing on drug prices.
No hay comentarios:
Publicar un comentario